Announcements Trials
Browse Landscape

Status

Unknown 2

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Observational 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Breast Neoplasms 9Triple Negative Breast Neoplasms 5Stomach Neoplasms 2Neoplasm Metastasis 2Uterine Cervical Neoplasms 1Pathologic Complete Response 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Lung Neoplasms 1Liver Neoplasms 1HER2-negative Breast Cancer 1Gastric Adenocarcinoma 1Gallbladder Neoplasms 1Fallopian Tube Neoplasms 1Esophageal Neoplasms 1Colonic Neoplasms 1Carcinoma, Ovarian Epithelial 1Brain Neoplasms 1Biliary Tract Neoplasms 1

Interventions

Oxaliplatin 200Capecitabine 116S 1 (combination) 106Fluorouracil 105Docetaxel 100Cisplatin 88Leucovorin 75Paclitaxel 71Irinotecan 68apatinib 43sintilimab 42Drug Therapy 42Surgical Procedures, Operative 37Hyperthermic Intraperitoneal Chemotherapy 34pembrolizumab 32Radiotherapy 31Trastuzumab 30Gastrectomy 23Nivolumab 22Epirubicin 22Tegafur 21Bevacizumab 21XELOX 20titanium silicide 19camrelizumab 19tislelizumab 17Ramucirumab 17Carboplatin 16Neoadjuvant Therapy 15Endoscopic Mucosal Resection 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Stomach Neoplasms × taxane × Clear all
NCT04915807 2021-06-07

Real-world Data (RWD) of Ramucirumab Plus Paclitaxel

Hallym University Medical Center

Unknown
222 enrolled
Gastrointestinal

Stomach Neoplasms

NCT03668418 2018-09-12

xenoZ

University of Pisa

Unknown
120 enrolled
Gastrointestinal

Biliary Tract Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Liver Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡